Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 155 No. 5 (2025)

Did the COVID-19 pandemic impact paediatric health service utilisation in Switzerland? Interrupted time-series models of health insurance data

Cite this as:
Swiss Med Wkly. 2025;155:3899
Published
15.05.2025

Summary

BACKGROUND: There is a scarcity of studies that examined the impact of the COVID-19 pandemic on different primary paediatric health services beyond the first pandemic year and with longitudinal analytical approaches. Concerning Switzerland, studies are also lacking that assessed the impact of the pandemic on primary paediatric health services with objective and representative data. The current study addresses these research gaps.

METHODS: Representative Swiss health insurance data (covering 96% of the population) of 0–18-year-olds, aggregated by month and by age groups 0–5, 6–10, 11–15 and 16–18 years were used for the analyses. The study period was from January 2018 to March 2022. Interrupted time-series models were applied to compare pandemic and pre-pandemic health care utilisation. The first lockdown served as the point of differentiation between these two periods. Regular visits, urgent visits, well-child visits and telephone consultations as well as routine vaccinations in the primary care setting were used as outcomes.

RESULTS: Among 0–5-year-olds, the average utilisation rates of regular, urgent and well-child visits were statistically significantly lower during the pandemic compared to the pre-pandemic period. This decrease in utilisation was primarily due to an initial marked drop after the lockdown, followed by a partial recovery during the pandemic phase. Additionally, the average vaccination rates for measles/mumps/rubella were statistically significantly lower during the pandemic for this age group, without indication of a catch-up over the pandemic phase. For 6–10-year-olds, a decreased average utilisation of regular and urgent visits was found without a statistically significant recovery over the pandemic period. No statistically significant changes were shown for older age groups regarding regular or urgent visits. However, telephone consultations showed statistically significantly higher average utilisation rates during the pandemic compared to the pre-pandemic phase across all age groups.

CONCLUSIONS: Delayed or missed well-child visits, which might persist even after a certain recovery, pose the risk of delayed detection of clinical/developmental abnormalities. Furthermore, missed vaccinations for measles/mumps/rubella increase the likelihood of infections and outbreaks, which can be particularly dangerous for the youngest children. Therefore, promoting catch-up well-child visits and vaccinations is essential. Higher utilisation of telephone consultations during the pandemic may have partially compensated the underutilisation of face-to-face consultations/visits in young children. In adolescents, in whom no changes in the utilisation of face-to-face consultations were observed, the increased use of telephone consultations may indicate an increase in health concerns within this age group.

References

  1. WHO. WHO Coronavirus (COVID-19) Dashboard. 2023. Available from: https://covid19.who.int/
  2. Treskova-Schwarzbach M, Haas L, Reda S, Pilic A, Borodova A, Karimi K, et al. Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence. BMC Med. 2021 Aug;19(1):212. doi: https://doi.org/10.1186/s12916-021-02058-6
  3. Cohen JF, Korevaar DA, Matczak S, Chalumeau M, Allali S, Toubiana J. COVID-19-Related Fatalities and Intensive-Care-Unit Admissions by Age Groups in Europe: A Meta-Analysis. Front Med (Lausanne). 2021 Jan;7:560685. doi: https://doi.org/10.3389/fmed.2020.560685
  4. Mehraeen E, Oliaei S, SeyedAlinaghi S, Karimi A, Mirzapour P, Afsahi AM, et al. COVID-19 in pediatrics: a systematic review of current knowledge and practice. IDDT. 2022 Aug;22(5):e290921196908.
  5. Huss G, Magendie C, Pettoello-Mantovani M, Jaeger-Roman E. Implications of the COVID-19 Pandemic for Pediatric Primary Care Practice in Europe. J Pediatr. 2021 Jun;233:290–291.e2. doi: https://doi.org/10.1016/j.jpeds.2021.03.004
  6. Locke J, Marinkovic A, Hamdy K, Balendra V, Sanyaolu A. Routine pediatric vaccinations during the COVID-19 pandemic: A review of the global impact. World J Virol. 2023 Dec;12(5):256–61. doi: https://doi.org/10.5501/wjv.v12.i5.256
  7. Immunization coverage. WHO; Available from: https://www.who.int/news-room/fact-sheets/detail/immunization-coverage
  8. Lebrun-Harris LA, Sappenfield OR, Warren MD. Missed and delayed preventive health care visits among US children due to the COVID-19 pandemic. Public Health Rep. 2022;137(2):336–43. doi: https://doi.org/10.1177/00333549211061322
  9. Vogel M, Beger C, Gausche R, Jurkutat A, Pfaeffle R, Körner A, et al. COVID-19 pandemic and families’ utilization of well-child clinics and pediatric practices attendance in Germany. BMC Res Notes. 2021 Apr;14(1):140. doi: https://doi.org/10.1186/s13104-021-05562-3
  10. Siedner MJ, Kraemer JD, Meyer MJ, Harling G, Mngomezulu T, Gabela P, et al. Access to primary healthcare during lockdown measures for COVID-19 in rural South Africa: an interrupted time series analysis. BMJ Open. 2020 Oct;10(10):e043763. doi: https://doi.org/10.1136/bmjopen-2020-043763
  11. Li H, Yu G, Duan H, Fu J, Shu Q. Changes in Children’s Healthcare Visits During Coronavirus Disease-2019 Pandemic in Hangzhou, China. J Pediatr. 2020/05/19 ed. 2020 Sep;224:146–9.
  12. Brown CL, Montez K, Amati JB, Simeonsson K, Townsend JD, Orr CJ, et al. Impact of COVID-19 on pediatric primary care visits at four academic institutions in the Carolinas. Int J Environ Res Public Health. 2021 May;18(11):5734. doi: https://doi.org/10.3390/ijerph18115734
  13. Thakkar PV, Scott Z, Hoffman M, Delarosa J, Hickerson J, Boutzoukas AE, et al. Impact of the COVID-19 Pandemic on Pediatric Preventive Health Care Among North Carolina Children Enrolled in Medicaid. J Pediatric Infect Dis Soc. 2023 Dec;12 Supplement_2:S14–9. doi: https://doi.org/10.1093/jpids/piad061
  14. Evans A, Mahar AL, Deb B, Boblitz A, Brownell M, Guttmann A, et al. Gaps in childhood immunizations and preventive care visits during the COVID-19 pandemic: a population-based cohort study of children in Ontario and Manitoba, Canada, 2016-2021. Can J Public Health. 2023 Oct;114(5):774–86. doi: https://doi.org/10.17269/s41997-023-00797-y
  15. Barschkett M, Koletzko B, Spiess CK. COVID-19 associated contact restrictions in Germany: marked decline in children’s outpatient visits for infectious diseases without increasing visits for mental health disorders. Children (Basel). 2021 Aug;8(9):728. doi: https://doi.org/10.3390/children8090728
  16. Schweiberger K, Patel SY, Mehrotra A, Ray KN. Trends in Pediatric Primary Care Visits During the Coronavirus Disease of 2019 Pandemic. Acad Pediatr. 2021;21(8):1426–33. doi: https://doi.org/10.1016/j.acap.2021.04.031
  17. Schmid-Küpke NK, Matysiak-Klose D, Siedler A, Felgendreff L, Wieler L, Thaiss HM, et al. Cancelled routine vaccination appointments due to COVID-19 pandemic in Germany. Vaccine X. 2021 Aug;8:100094. doi: https://doi.org/10.1016/j.jvacx.2021.100094
  18. Macy ML, Huetteman P, Kan K. Changes in primary care visits in the 24 weeks after COVID-19 stay-at-home orders relative to the comparable time Period in 2019 in Metropolitan Chicago and Northern Illinois. J Prim Care Community Health. 2020;11:2150132720969557. doi: https://doi.org/10.1177/2150132720969557
  19. Grossman Z, Chodick G, Reingold SM, Chapnick G, Ashkenazi S. The future of telemedicine visits after COVID-19: perceptions of primary care pediatricians. Isr J Health Policy Res. 2020 Oct;9(1):53. doi: https://doi.org/10.1186/s13584-020-00414-0
  20. Taquechel K, Diwadkar AR, Sayed S, Dudley JW, Grundmeier RW, Kenyon CC, et al. Pediatric Asthma Health Care Utilization, Viral Testing, and Air Pollution Changes During the COVID-19 Pandemic. J Allergy Clin Immunol Pract. 2020;8(10):3378–3387.e11. doi: https://doi.org/10.1016/j.jaip.2020.07.057
  21. Castrejon MM, Leal I, de Jesus Pereira Pinto T, Guzmán-Holst A. The impact of COVID-19 and catch-up strategies on routine childhood vaccine coverage trends in Latin America: A systematic literature review and database analysis. Hum Vaccin Immunother. 2022 Nov;18(6):2102353. doi: https://doi.org/10.1080/21645515.2022.2102353
  22. Seiler M, Goldman RD, Staubli G, Hoeffe J, Gualco G, Manzano S; Swiss Medical Weekly. Parents’ intent to vaccinate against influenza during the COVID-19 pandemic im two regions in Switzerland. Swiss Med Wkly. 2021 May;151(1920):w20508. doi: https://doi.org/10.4414/smw.2021.20508
  23. FOPH. Kantonales Durchimpfungsmonitoring Schweiz. Available from: https://www.bag.admin.ch/bag/de/home/gesund-leben/gesundheitsfoerderung-und-praevention/impfungen-prophylaxe/informationen-fachleute-gesundheitspersonal/durchimpfung.html
  24. Rachamin Y, Jäger L, Schweighoffer R, Signorell A, Bähler C, Huber CA, et al. The Impact of COVID-19 on Mental Healthcare Utilization in Switzerland Was Strongest Among Young Females-Retrospective Study in 2018-2020. Int J Public Health. 2023 May;68:1605839. doi: https://doi.org/10.3389/ijph.2023.1605839
  25. Schweizerischer Impfplan 2022. Richtlinien und Empfehlungen. Bundesamt für Gesundheit und Eidgenössische Kommission für Impffragen; 2022.
  26. Schweizerischer Impfplan 2021. Richtlinien und Empfehlungen. Bundesamt für Gesundheit und Eidgenössische Kommission für Impffragen; 2021.
  27. Ambühl D, Bächler A, Baumann T, Jenni O, Leuchter Ha-Vinh R, Lips U, et al. Checklisten für die Vorsorgeuntersuchungen nach den Empfehlungen der Schweizerischen Gesellschaft für Pädiatrie. Arbeitsgruppe der SGP; 2012.
  28. Schweizerischer Impfplan 2018. Richtlinien und Empfehlungen. Bundesamt für Gesundheit und Eidgenössische Kommission für Impffragen; 2018.
  29. Schweizerischer Impfplan 2019. Richtlinien und Empfehlungen. Bundesamt für Gesundheit und Eidgenössische Kommission für Impffragen; 2019.
  30. Schweizerischer Impfplan 2020. Richtlinien und Empfehlungen. Bundesamt für Gesundheit und Eidgenössische Kommission für Impffragen; 2020.
  31. StataCorp. Stata Statistical Software: Release 17.0. College Station (TX): StataCorp LLC; 2021.
  32. Kirkland DA, Svynarenko R, Lindley LC. Scoping Review: Telehealth During the Coronavirus Disease 2019 Pandemic for Pediatric Populations. J Nurse Pract. 2024 Feb;20(2):104884. doi: https://doi.org/10.1016/j.nurpra.2023.104884
  33. Weber P, Jenni O. Screening in child health - studies of the efficacy and relevance of preventive care practices. Deutsches Ärzteblatt international. 2012 Jun 15; Available from: https://www.aerzteblatt.de/10.3238/arztebl.2012.0431
  34. Nelson CS, Wissow LS, Cheng TL. Effectiveness of anticipatory guidance: recent developments. Curr Opin Pediatr. 2003 Dec;15(6):630–5. doi: https://doi.org/10.1097/00008480-200312000-00015
  35. Weisz J, Krueger J, Henriques J, Lacy M, Gai J, Boogaard C. Barriers to Infant Preventive Care During the COVID-19 Pandemic. Clin Pediatr (Phila). 2022 Jan;61(1):17–21. doi: https://doi.org/10.1177/00099228211050476
  36. Di Mattia G, Nenna R, Mancino E, Rizzo V, Pierangeli A, Villani A, et al. During the COVID-19 pandemic where has respiratory syncytial virus gone? Pediatr Pulmonol. 2021 Oct;56(10):3106–9. doi: https://doi.org/10.1002/ppul.25582
  37. Law BJ, Carbonell-Estrany X, Simoes EA. An update on respiratory syncytial virus epidemiology: a developed country perspective. Respir Med. 2002 Apr;96 Suppl B:S1–7. doi: https://doi.org/10.1053/rmed.2002.1294
  38. Cheng CW, Huang YB, Chao HY, Ng CJ, Chen SY. Impact of the COVID-19 Pandemic on Pediatric Emergency Medicine: A Systematic Review. Medicina (Kaunas). 2022 Aug;58(8):1112. doi: https://doi.org/10.3390/medicina58081112
  39. Watson G, Pickard L, Williams B, Hargreaves D, Blair M. ‘Do I, don’t I?’ A qualitative study addressing parental perceptions about seeking healthcare during the COVID-19 pandemic. Arch Dis Child. 2021 Nov;106(11):1118–24. doi: https://doi.org/10.1136/archdischild-2020-321260
  40. Panchal U, Salazar de Pablo G, Franco M, Moreno C, Parellada M, Arango C, et al. The impact of COVID-19 lockdown on child and adolescent mental health: systematic review. Eur Child Adolesc Psychiatry. 2023 Jul;32(7):1151–77.
  41. Samji H, Wu J, Ladak A, Vossen C, Stewart E, Dove N, et al. Review: mental health impacts of the COVID-19 pandemic on children and youth - a systematic review. Child Adolesc Ment Health. 2022 May;27(2):173–89. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/camh.12501 10.1111/camh.12501
  42. Kodjebacheva GD, Culinski T, Kawser B, Amin S. Satisfaction with pediatric telehealth according to the opinions of children and adolescents during the COVID-19 pandemic: A literature review. Front Public Health. 2023 Apr;11:1145486. doi: https://doi.org/10.3389/fpubh.2023.1145486
  43. Tully L, Case L, Arthurs N, Sorensen J, Marcin JP, O’Malley G. Barriers and Facilitators for Implementing Paediatric Telemedicine: Rapid Review of User Perspectives. Front Pediatr. 2021 Mar;9:630365. doi: https://doi.org/10.3389/fped.2021.630365
  44. Richard JL, Mäusezahl M, Basler S, Eckert N. Approaching measles elimination in Switzerland: changing epidemiology 2007-2018. Swiss Med Wkly. 2019 Jun;149:w20102. 10.4414/smw.2019.20102
  45. Baroutsou V, Wymann M, Zens K, Sinniger P, Fehr J, Lang P. National and regional variations in timely adherence to recommended measles vaccination scheme in 2-years old in Switzerland, 2005-2019. Vaccine. 2022 May;40(22):3055–63. doi: https://doi.org/10.1016/j.vaccine.2022.04.008
  46. 8th meeting of the European regional verification commission for measles and rubella elimination (RVC). Warsaw, Poland: WHO, regional office for Europe; Available from: https://www.who.int/europe/publications/i/item/WHO-EURO-2019-3623-43382-60860
  47. Schneider R, Reinau D, Schur N, Blozik E, Früh M, Signorell A, et al. Coverage rates and timeliness of nationally recommended vaccinations in Swiss preschool children: A descriptive analysis using claims data. Vaccine. 2020 Feb;38(6):1551–8. doi: https://doi.org/10.1016/j.vaccine.2019.11.057